阿尼卡医疗 ANIK 深 沪
等待开盘 05-12 09:30:00 美东时间
14.49
-0.280
-1.90%
华盛通- 最 高15.3599
- 今 开14.80
- 成交量 5.02万股
- 最 低 14.225
- 昨 收 14.77
- 总市值 21.07万
- 52周最高 16.24
- 市盈率 静 51.29
- 换手率 345.05%
- 52周最低 7.90
- 委 比 -39.29%
- 总股本 1.45万
- 历史最高 75.715
- 量 比 0.41
- 振 幅 7.68%
- 历史最低 1.10
- 每 手 1
- 风险率 2.03%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Earnings Scheduled For February 26, 2026
Companies Reporting Before The Bell • Enovis (NYSE:ENOV) is estimated to report...
02-26 19:11
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Anika Therapeutics granted 2,500 stock options to a new employee at $11.45 per share, vesting annually over three years, under its 2021 Inducement Plan.
2025-06-05 21:00
ANI Pharmaceuticals to Present at the 2025 Jefferies Global Healthcare Conference
ANI Pharmaceuticals' CEO, Nikhil Lalwani, will present at the 2025 Jefferies Global Healthcare Conference on June 4, 2025, at 2:35pm ET. The live and archived webcast will be available on the Company’s website under the Investors section.
2025-05-27 20:30
ANI Pharmaceuticals Announces Initiation of Phase 4 Clinical Trial of Purified Cortrophin® Gel for the Treatment of Acute Gout Flares
ANI Pharmaceuticals announced a Phase 4 clinical trial comparing two dose levels of Purified Cortrophin Gel for treating acute gout flares, evaluating safety and efficacy.
2025-05-22 10:50
